Comparing two forms of a study drug in healthy volunteers
Part of Immune system & allergy, Lungs & breathing clinical trials.
This trial compares two different forms of an investigational drug to see how they are absorbed into the body. It is for healthy volunteers who want to help researchers understand the safest and most effective way to give the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be in good general health with no major medical problems.
- You must weigh at least 110 pounds (50 kg) and have a healthy body mass index (BMI) between 19 and 30.
- If you are a woman, you must be unable to become pregnant (e.g., postmenopausal or surgically sterilized).
- You cannot be a current smoker or have a heavy smoking history (more than 10 pack-years).
- You must not have taken any biologic medications (like injectable antibody drugs) in the last 3 months.
- You must agree to not receive any live vaccines during the study and for 1 month before starting.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
This study is testing an investigational medication for people with uncontrolled asthma. Participants must have moderate-to-severe asthma, be on appropriate maintenance therapy, and meet specific safety criteria.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
This study tests an investigational medication (SKB575) for people with asthma. It aims to see if the drug is safe and works better than a placebo when added to your regular asthma treatments.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.